| Customization: | Available |
|---|---|
| Certification: | BRC, ISO, HACCP |
| Assay Method: | HPLC-MS, UV |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
PRL-8-53 is a synthetic nootropic supplement. Its full name is methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate. PRL-8-53 is used to treat vascular dementia and Alzheimer's disease with mild and moderate learning, memory and cognitive dysfunction. It is also used for patients with memory loss after stroke, benign memory impairment in middle-aged and elderly, and children with brain development delay.
| Product name: PRL-8-53 |
| Other names: Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hy |
| CAS NO.: 51352-87-5 |
| M.F.: C18H22ClNO2 |
| M.W.: 319.826 |
| Melting point: N/A |
| Boiling point: 398.9ºC at 760 mmHg |
){kind=link}